LivaNova (LIVN) Net Income Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 99.11% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4,440.69% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.10% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | 107.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 107.07% |
| Dec 31, 2025 | -44.69% |
| Sep 30, 2025 | -18.59% |
| Jun 30, 2025 | 66.05% |
| Mar 31, 2025 | -680.83% |
| Dec 31, 2024 | 241.72% |
| Sep 30, 2024 | 551.77% |
| Jun 30, 2024 | 1,283.09% |
| Mar 31, 2024 | -666.68% |
| Dec 31, 2023 | 867.81% |
| Sep 30, 2023 | 93.22% |
| Jun 30, 2023 | -92.82% |
| Mar 31, 2023 | 143.96% |
| Dec 31, 2020 | -366.31% |
| Dec 31, 2019 | 118.30% |
| Jun 30, 2019 | 103.99% |
| Dec 31, 2018 | 98.73% |
| Sep 30, 2018 | -210.92% |
| Jun 30, 2018 | -345.30% |
| Mar 31, 2018 | -132.57% |
| Dec 31, 2017 | -241.51% |
| Sep 30, 2017 | 110.19% |
| Jun 30, 2017 | 148.12% |
| Mar 31, 2017 | 93.34% |
| Dec 31, 2016 | -57.75% |
| Dec 31, 2015 | -448.05% |
| Oct 18, 2015 | -245.26% |
| Apr 24, 2015 | -84.18% |